The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies.
作者信息
Huang Kun
机构信息
Department of Pediatrics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
出版信息
JMIR Public Health Surveill. 2024 Mar 13;10:e51372. doi: 10.2196/51372.
Abstract
摘要
相似文献
1
The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies.血友病研究中特定出血类型年出血率的必要性。
JMIR Public Health Surveill. 2024 Mar 13;10:e51372. doi: 10.2196/51372.
2
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies".作者回复：“血友病研究中特定出血类型年出血率的必要性”
JMIR Public Health Surveill. 2024 Mar 13;10:e54756. doi: 10.2196/54756.
3
Association between physical activity and risk of bleeding in children with hemophilia.体力活动与儿童血友病出血风险的关联。
JAMA. 2012 Oct 10;308(14):1452-9. doi: 10.1001/jama.2012.12727.
4
Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study.定量评估中国成人甲型血友病患者预防性治疗的获益-风险权衡：离散选择实验研究。
JMIR Public Health Surveill. 2023 Jul 26;9:e45747. doi: 10.2196/45747.
5
A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand.血友病 B 旁路制剂预防与按需使用重组因子 VIIa 的预算影响模型。
J Manag Care Spec Pharm. 2016 Feb;22(2):149-57. doi: 10.18553/jmcp.2016.22.2.149.
6
The bleeding phenotype in people with nonsevere hemophilia.非重型血友病患者的出血表型。
Blood Adv. 2022 Jul 26;6(14):4256-4265. doi: 10.1182/bloodadvances.2022007620.
7
Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.伴有因子VIII和因子IX抑制剂的血友病、发病率、出血问题及管理
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:106-12.
8
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A.评估基因疗法治疗甲型血友病的潜在成本效益。
J Med Econ. 2020 May;23(5):501-512. doi: 10.1080/13696998.2020.1721508. Epub 2020 Feb 13.
9
Phenotypic heterogeneity in severe hemophilia.重度血友病的表型异质性。
J Thromb Haemost. 2007 Jul;5 Suppl 1:151-6. doi: 10.1111/j.1538-7836.2007.02503.x.
10
Spinal Epidural Bleed in Hemophilia: A Rare Site of Bleeding With Complete Resolution With Nonsurgical Management.
J Pediatr Hematol Oncol. 2019 Apr;41(3):215-217. doi: 10.1097/MPH.0000000000001335.
引用本文的文献
1
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies".作者回复：“血友病研究中特定出血类型年出血率的必要性”
JMIR Public Health Surveill. 2024 Mar 13;10:e54756. doi: 10.2196/54756.
本文引用的文献
1
Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study.定量评估中国成人甲型血友病患者预防性治疗的获益-风险权衡：离散选择实验研究。
JMIR Public Health Surveill. 2023 Jul 26;9:e45747. doi: 10.2196/45747.
2
Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A.基于个体化目标 FVIII 浓度阈值的个体化预防治疗可优化重度 A 型血友病患儿的临床结局。
Haemophilia. 2022 Nov;28(6):e209-e218. doi: 10.1111/hae.14635. Epub 2022 Jul 18.
3
Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study.荷兰血友病患者与普通人群相似的运动参与度；一项全国性研究的结果。
Haemophilia. 2021 Sep;27(5):876-885. doi: 10.1111/hae.14366. Epub 2021 Jun 19.
4
WFH Guidelines for the Management of Hemophilia, 3rd edition.《血友病管理的居家指南》第三版
Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3.
5
Understanding minimum and ideal factor levels for participation in physical activities by people with haemophilia: An expert elicitation exercise.了解血友病患者参与体育活动的最低和理想因子水平：一项专家 elicitation 研究。
Haemophilia. 2020 Jul;26(4):711-717. doi: 10.1111/hae.13985. Epub 2020 Apr 8.
Zotero 插件